Toggle Nav
Close
  • Menu
  • Setting

Anti-FOLR1/FRA Antibody (Farletuzumab-MMAE)

Catalog No.
F1555
Anti-FOLR1/FRA Antibody (Farletuzumab-MMAE)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-α (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has potent antitumor activity.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145 kDa

Shipping

Dry ice

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

farletuzumab-MMAE

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P15328

Reactivity

Human

Conjugation

MMAE

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized human FRα His at 2 ug/mL can bind Anti-FOLR1/FRA Antibody (Farletuzumab-MMAE)

Target

FOLR1 / FRA

Note

Please avoid freeze-thaw cycles.